Innovations in Immunoassays, Cancer Detection, Ophthalmic Disease Detection, Vital Signs Monitoring, CT Systems, and Ultrasound Imaging Systems

Share this:
     
Published: 27 Apr 2018

The latest issue of Medical Imaging and Diagnostics TOE profiles innovations in the medical imaging and diagnostics industry. Some of the profiles covered include development of an automated immunoassay to detect Zika virus, artificial mole for cancer detection, artificial intelligence platform to detect diabetic retinopathy, brain mapping technology, urine test to detect cancer, continuous vital signs monitoring, ultra-fast ultrasound imaging, and mobile CT imaging. Medical Imaging and Diagnostics TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Automated immunoassay, cancer detection, artificial intelligence, brain mapping, urine test, remote patient management, ultra-high resolution CT system, ultra-fast ultrasound imaging, mobile CT imaging

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..